EyePoint Pharmaceuticals (EYPT) Revenue: 2010-2018
Historic Revenue for EyePoint Pharmaceuticals (EYPT) over the last 9 years, with Jun 2018 value amounting to $3.0 million.
- EyePoint Pharmaceuticals' Revenue rose 26.23% to $486,000 in Q3 2018 from the same period last year, while for Sep 2018 it was $2.2 million, marking a year-over-year decrease of 70.85%. This contributed to the annual value of $3.0 million for FY2018, which is 60.72% down from last year.
- Latest data reveals that EyePoint Pharmaceuticals reported Revenue of $3.0 million as of FY2018, which was down 60.72% from $7.5 million recorded in FY2017.
- Over the past 5 years, EyePoint Pharmaceuticals' Revenue peaked at $26.6 million during FY2015, and registered a low of $1.6 million during FY2016.
- Moreover, its 3-year median value for Revenue was $3.0 million (2018), whereas its average is $4.0 million.
- Its Revenue has fluctuated over the past 5 years, first surged by 664.90% in 2015, then slumped by 93.90% in 2016.
- EyePoint Pharmaceuticals' Revenue (Yearly) stood at $3.5 million in 2014, then spiked by 664.90% to $26.6 million in 2015, then slumped by 93.90% to $1.6 million in 2016, then spiked by 365.37% to $7.5 million in 2017, then plummeted by 60.72% to $3.0 million in 2018.